Actipulse Neuroscience
PrivateLast Round
Seed
Jan 25, 2022
Total Funding Raised
$871,600
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Actipulse Neuroscience operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Seed round in January 2022.
Actipulse Neuroscience is a neurotechnology company that develops non-invasive brain stimulation devices for the treatment of psychiatric and neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Mental Health
Business Model
B2B
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Actipulse Neuroscience Comparables
Compare Actipulse Neuroscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neurolief | 87% | |
| Flow Neuroscience | 83% | |
| Sooma | 83% |
For institutional investors. Book with your work email.
Actipulse Neuroscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 25, 2022 | ||||
| SAFE | Nov 17, 2021 | ||||
| Accelerator | Oct 30, 2019 | ||||
| Grant | May 4, 2018 |
For institutional investors. Book with your work email.
Actipulse Neuroscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Start-Up Chile | Grant |
| MassChallenge Israel | Accelerator |
| Y Combinator | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 147% MoM.
- Feb 27, 2022
$500K round led by Y Combinator
For institutional investors. Book with your work email.
Actipulse Neuroscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Actipulse Neuroscience's valuation, stock price, and market status.
Is Actipulse Neuroscience a public or private company?
Actipulse Neuroscience is a private company.
What is the current stock price of Actipulse Neuroscience?
Actipulse Neuroscience is a private company, so its shares have no public market price. Caplight tracks Actipulse Neuroscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Actipulse Neuroscience worth (valuation)?
Valuation information for Actipulse Neuroscience is not publicly available.
Can I buy Actipulse Neuroscience stock?
Actipulse Neuroscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Actipulse Neuroscience's last funding round?
Actipulse Neuroscience's most recent funding round was Seed on January 25, 2022.
Who are the main investors in Actipulse Neuroscience?
Key investors in Actipulse Neuroscience include Y Combinator.
Will Actipulse Neuroscience IPO soon?
No public IPO plans have been announced for Actipulse Neuroscience.
How can I track Actipulse Neuroscience secondary market activity?
Caplight tracks bids, offers, and trades in Actipulse Neuroscience's shares on secondary markets.